Cross-presentation of HLA class I epitopes from influenza matrix protein produced in Saccharomyces cerevisiae (Q79964508)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16860448%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

title

Cross-presentation of HLA class I epitopes from influenza matrix protein produced in Saccharomyces cerevisiae (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16860448%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

main subject

Saccharomyces cerevisiae

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16860448%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Carmen Scheibenbogen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16860448%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Andreas Wadle

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16860448%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Gerhard Held

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16860448%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Frank Neumann

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16860448%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Sascha Kleber

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16860448%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Beate Wuellner

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16860448%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Anne Marie Asemissen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16860448%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Boris Kubuschok

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16860448%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Tanja Breinig

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16860448%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Christoph Renner

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16860448%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

publication date

14 June 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16860448%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

number of pages

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16860448%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16860448%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

issue

37-39

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16860448%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

page(s)

6272-6281

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16860448%20AND%20SRC:MED&resulttype=core&format=json

Peptide-based vaccination for colorectal cancer

27 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.096

Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.096

Multiepitope CD8(+) T cell response to a NY-ESO-1 peptide vaccine results in imprecise tumor targeting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.096

CD8(+) T cell responses against a dominant cryptic HLA-A2 epitope after NY-ESO-1 peptide immunization of cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.096

Advances in vaccine adjuvants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.096

Granulocyte-macrophage-colony-stimulating factor enhances immune responses to melanoma-associated peptides in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.096

Interleukin-12 as an adjuvant for cancer immunotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.096

Polytope vaccines for the codelivery of multiple CD8 T-cell epitopes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.096

Competition Between CTL Narrows the Immune Response Induced by Prime-Boost Vaccination Protocols

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.096

Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4+ and CD8+ T cell responses in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.096

IFN-gamma enables cross-presentation of exogenous protein antigen in human Langerhans cells by potentiating maturation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.096

Dendritic cells: specialized and regulated antigen processing machines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.096

Antigen presentation and T cell stimulation by dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.096

Constitutive macropinocytosis allows TAP-dependent major histocompatibility complex class I presentation of exogenous soluble antigen by bone marrow-derived dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.096

Differential presentation of a soluble exogenous tumor antigen, NY-ESO-1, by distinct human dendritic cell populations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.096

Tumor antigen processing and presentation depend critically on dendritic cell type and the mode of antigen delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.096

Vaccination of mice against invasive aspergillosis with recombinant Aspergillus proteins and CpG oligodeoxynucleotides as adjuvants.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.096

The history of the development of vaccines for the treatment of lymphoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.096

Immunisation of metastatic cancer patients with MAGE-3 protein combined with adjuvant SBAS-2: a clinical report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.096

Whole recombinant yeast vaccine activates dendritic cells and elicits protective cell-mediated immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.096

Application of the IFN-gamma ELISPOT assay to quantify T cell responses against proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.096

Dissecting cytotoxic T cell responses towards the NY-ESO-1 protein by peptide/MHC-specific antibody fragments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.096

Phenotypic analysis of antigen-specific T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.096

Antibody-conjugated MHC class I tetramers can target tumor cells for specific lysis by T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.096

Multi-subunit proteins on the surface of filamentous phage: methodologies for displaying antibody (Fab) heavy and light chains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.096

Secretion of beta-lactamase into the periplasm of Escherichia coli: evidence for a distinct release step associated with a conformational change

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.096

Generation of high-affinity human antibodies by combining donor-derived and synthetic complementarity-determining-region diversity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.096

Serological identification of breast cancer-related antigens from a Saccharomyces cerevisiae surface display library

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.096

Immobilizing proteins on the surface of yeast cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.096

Yeast-derived human immunodeficiency virus type 1 p55(gag) virus-like particles activate dendritic cells (DCs) and induce perforin expression in Gag-specific CD8(+) T cells by cross-presentation of DCs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.096

Toll-like receptors: key mediators of microbe detection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.096

Extensive MHC class I-restricted CD8 T lymphocyte responses against various yeast genera in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.096

Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.096

Toll-like receptors as key mediators in innate antifungal immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.096

Turning it on and off: regulation of dendritic cell function in Toxoplasma gondii infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.096

Identification of antigens reacting with anti-Candida albicans germ tube antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.096

10.1016/J.VACCINE.2006.05.096

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16860448%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16860448%20AND%20SRC:MED&resulttype=core&format=json